IP Library Granted Patent US 10,745,705
Granted Patent B2
US 10,745,705 · App. 15/545,275 · Granted Aug 18, 2020

Ribosome-mediated incorporation of peptides and peptidomimetics

Inventors: Sidney Hecht (Phoenix, AZ); Larisa (Liza) Dedkova (Scottsdale, AZ); Rumit Maini (Tempe, AZ); Sandipan Roy Chowdhury (Tempe, AZ); Rakesh Paul (Baltimore, MD)
Assignee: ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
C12N15/67C07D263/34C07D277/593C12N9/003C12N15/11C12Y105/01003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,745,705
App. No.
15/545,275
Granted
Aug 18, 2020
Kind
B2
Abstract

Modified ribosomes that were selected using a dipeptidyl-puromycin aminonucleoside are used to mediate site-specific incorporation of one or more peptides and peptidomimetics into protein in a cell free translation system. In addition, new fluorescent dipeptidomimetics have been synthesized and incorporated into proteins, as well as modified proteins containing one or more non-naturally occurring dipeptides.

Claims (113)

1. An in vitro translation system comprising materials sufficient to effect translation from a messenger RNA (mRNA), comprising:

a transfer RNA (tRNA) with modified dipeptidomimetic

 and

a genetically modified ribosome having a 23S ribosomal RNA (rRNA) sequence modification selected from the group consisting of one or more modification(s) selected from the following:

Region 1

2056

2057

2058

2059

2060

2061

2062

2063

2064

G

U

G

C

G

U

G

G

C

A

U

A

A

Region 2

2501

2502

2503

2504

2505

2506

2507

2508

C

U

C

G

U

G

U

G

A

U

A

A

A

A

C

G

C

C

C

G.

2. The system of claim 1 , wherein said materials comprise an E. coli S-30 extract.

3. A method for producing a modified peptide, polypeptide, or protein, comprising the step of:

providing to an in vitro translation system a transfer RNA (tRNA) with modified dipeptidomimetic

 said system comprising materials sufficient to effect translation from a messenger RNA (mRNA) and containing a genetically modified ribosome having a 23 S ribosomal RNA (rRNA) sequence modification selected from the group consisting of one or more modification(s) selected from the following:

Region 1

2056

2057

2058

2059

2060

2061

2062

2063

2064

G

U

G

C

G

U

G

G

C

A

U

A

A

Region 2

2501

2502

2503

2504

2505

2506

2507

2508

C

U

C

G

U

G

U

G

A

U

A

A

A

A

C

G

C

C

C

G.

4. The method of claim 3 , wherein said materials include a mRNA encoding the protein(s) of interest and containing one or more stop codons, and one or more suppressor tRNA(s) activated with the modified dipeptidomimetic recognized by the selected ribosomes.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 7, 2017
From: ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044753/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: HECHT, SIDNEY; DEDKOVA, LARISA; MAINI, RUMIT; ROY CHOWDHURY, SANDIPAN; PAUL, RAKESH
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 043058/0770 →
Continuity (2)
Provisional Application 62106958 · Jan 23, 2015
Related Publication 20180002709A1 · Jan 4, 2018